Daily Agent Brief — What Our AI Agents Found Today

SEMICONDUCTORS GROWTH RESEARCH

Semiconductor Research

% = share price change, close 27 Aug → 25 Sep 2026

01

AVGO Broadcom −5.00% month

AI revenue surge FY27-28

Q3 AI semiconductor revenue $16.7B, up 221% YoY; Q4 expected $21.7B.

RISKSix major customers represent majority of revenue

02

MU Micron +15.70% month

HBM demand record FY27

Fiscal Q3 revenue $41.46B, up 346% YoY; Cloud Memory $13.77B at 83% margin.

RISKHBM4E volume production delayed to calendar 2027

03

AMAT Applied Materials +0.50% month

Record Q3 results FY27

Q3 revenue $9.12B, up 25% YoY; Semiconductor Systems $7.04B, up 26.6% YoY.

RISKNon-GAAP gross margin 50.4% below historical levels

WHAT THE AGENT FOUND

AI semiconductor demand accelerates across memory, networking, and equipment. Broadcom leads custom AI accelerator revenue; Micron dominates HBM supply; Applied Materials benefits from capacity investments.

3 sources · 0 filings →

% = share price change, close 27 Aug → 25 Sep 2026

AVGO −5.00% month

AI revenue surge then MU · AMAT

Q3 AI semiconductor revenue $16.7B, up 221% YoY; Q4 expected $21.7B.

Add to my account Full analysis →

3 sources · 0 filings →

Agent-generated research. May contain errors or omissions. Informational only — not investment advice, not a recommendation to buy or sell any security. Quotes via Yahoo Finance (unaffiliated).

HYPERSCALERS GROWTH RESEARCH

Hyperscaler Research

% = share price change, close 20 Sep → 20 Dec 2025

01

AMZN Amazon −2.10% month

Capex doubled guidance FY2026

AWS revenue up 24% in Q4; $200B capex guidance signals capacity-constrained growth.

RISKFree cash flow fell 71% YoY; capex consuming 94% of operating cash flow

02

GOOGL Alphabet +3.80% month

Cloud revenue up 30% 2025 (capex guided)

Google Cloud $12B in Q4, up 30% YoY; capex guidance raised to $75B for 2025.

RISKCloud profitability lags AWS; capex intensity rising while margins compress

03

ORCL Oracle +1.20% month

Backlog record $553B FY2027 (guided)

OCI revenue $4.9B, up 84% YoY; RPO $553B, up 325% YoY; FY2027 revenue guidance $90B.

RISKCapex $50B announced vs. $60-200B at peers; execution risk from workforce restructuring

WHAT THE AGENT FOUND

AWS, Google Cloud, and Oracle OCI all report capacity-constrained growth with record capex guidance. Amazon and Alphabet lead on revenue growth; Oracle leads on backlog conversion and margin expansion.

6 sources · 2 filings →

% = share price change, close 20 Sep → 20 Dec 2025

AMZN −2.10% month

Capex doubled guidance then GOOGL · ORCL

AWS revenue up 24% in Q4; $200B capex guidance signals capacity-constrained growth.

Add to my account Full analysis →

6 sources · 2 filings →

Agent-generated research. May contain errors or omissions. Informational only — not investment advice, not a recommendation to buy or sell any security. Quotes via Yahoo Finance (unaffiliated).

ENERGY GROWTH RESEARCH

Energy Research

% = share price change, close 14 Aug → 25 Sep 2026

01

PR Permian Resources −0.65% month

Guidance raised FY 2026

Oil production guidance raised to 199 MBbls/d, 10% above 2025.

RISKNegative gas prices curtail high-GOR production growth.

02

XOM ExxonMobil +0.31% month

Permian record high Through 2030

Record Permian production 1.8 Moebd; Fifth Guyana FPSO Q4 2026.

RISKMiddle East disruptions offset upstream earnings gains.

03

COP ConocoPhillips +0.41% month

LNG offtake expanded FY 2026

Increased LNG offtake to 12 MTPA; Iraq Kirkuk acquisition 42%.

RISKYear-over-year production down 143 MBOED from geopolitical impact.

WHAT THE AGENT FOUND

Three energy majors disclosed production growth through 2026–2030 via Permian expansion, Guyana development, and LNG contracts. Geopolitical risks and commodity price volatility constrain near-term execution.

3 sources · 0 filings →

% = share price change, close 14 Aug → 25 Sep 2026

PR −0.65% month

Guidance raised then XOM · COP

Oil production guidance raised to 199 MBbls/d, 10% above 2025.

Add to my account Full analysis →

3 sources · 0 filings →

Agent-generated research. May contain errors or omissions. Informational only — not investment advice, not a recommendation to buy or sell any security. Quotes via Yahoo Finance (unaffiliated).

BIOTECH GROWTH RESEARCH

Biotech Research

% = share price change, close 27 Aug → 25 Sep 2026

01

MRNA Moderna +39.30% month

Phase 3 melanoma success 9-trial program

First positive Phase 3 for mRNA cancer therapy across nine-trial INTerpath program.

RISKPersonalized manufacturing limits scalability and access.

02

VERA Vera Therapeutics −5.95% month

ORIGIN 3 efficacy confirmed Q4 2026 BLA filing

TRUTAKNA achieved 76% risk reduction in kidney disease progression; supplemental BLA planned Q4 2026.

RISKEarly commercial launch with 350+ patient starts in ten weeks.

03

AMLX Amylyx Pharmaceuticals −20.68% month

Phase 3 LUCIDITY met endpoints NDA by year-end 2026

Avexitide first-in-class GLP-1 antagonist for untreated indication; 55% reduction in hypoglycemic events.

RISKPost-bariatric hypoglycemia affects approximately 160,000 US patients.

WHAT THE AGENT FOUND

Three biotech leaders disclosed major Phase 3 trial milestones in the last 30 days. Moderna's mRNA cancer therapy achieved first positive Phase 3 readout; Vera's kidney disease drug showed 76% progression risk reduction; Amylyx's first-in-class hypoglycemia therapy met all endpoints.

3 sources · 1 filing →

% = share price change, close 27 Aug → 25 Sep 2026

MRNA +39.30% month

Phase 3 melanoma success then VERA · AMLX

First positive Phase 3 for mRNA cancer therapy across nine-trial INTerpath program.

Add to my account Full analysis →

3 sources · 1 filing →

Agent-generated research. May contain errors or omissions. Informational only — not investment advice, not a recommendation to buy or sell any security. Quotes via Yahoo Finance (unaffiliated).

DEFENSE GROWTH RESEARCH

Defense Research

% = share price change, close 27 Aug → 25 Sep 2026

01

RTX RTX −10.68% month

Tomahawk production acceleration Multi-year through 2033

Seven-year $22.9B contract to accelerate Tomahawk production to 1,000+ missiles annually.

RISKSupply chain dependencies across hundreds of suppliers

02

NOC Northrop Grumman −6.35% month

PAC-3 MSE framework agreements Capacity tripling by 2027

$3B+ in framework agreements for PAC-3 MSE motors and THAAD components with production surge planned.

RISKStock declined 18% in 30 days despite strong fundamentals

03

LHX L3Harris −9.27% month

PAC-3 MSE propulsion expansion New facilities operational 2027

$4.7B seven-year contract for PAC-3 MSE motors with two new Camden, Arkansas facilities under construction.

RISKNew production facilities not operational until 2027

WHAT THE AGENT FOUND

Three defense contractors disclosed major production acceleration contracts in the last 30 days. RTX, Northrop Grumman, and L3Harris are expanding capacity for missile interceptors and cruise missiles amid elevated global demand.

4 sources · 0 filings →

% = share price change, close 27 Aug → 25 Sep 2026

RTX −10.68% month

Tomahawk production acceleration then NOC · LHX

Seven-year $22.9B contract to accelerate Tomahawk production to 1,000+ missiles annually.

Add to my account Full analysis →

4 sources · 0 filings →

Agent-generated research. May contain errors or omissions. Informational only — not investment advice, not a recommendation to buy or sell any security. Quotes via Yahoo Finance (unaffiliated).

SPACE GROWTH RESEARCH

Space Research

% = share price change, close 27 Aug → 25 Sep 2026

01

VSAT Viasat +0.40% month

Constellation operational Now

ViaSat-3 F2 entered service Sept 17, completing constellation with 1+ Tbps capacity.

RISKHigh debt, slow cash flow ramp, unprofitable.

02

SPIR Spire Global −13.71% month

NOAA contract awarded Dec 2026–Dec 2028

$33.2M NOAA task order with $66M potential via options; five-year IDIQ eligibility.

RISKGovernment contract reliance, execution risk, revenue ramp challenges.

03

RKLB Rocket Lab +9.48% month

Space Force contract awarded 2026–2027

$397M Space Force SB-AMTI contract; develop, launch, operate Flatellites on Neutron.

RISKNeutron delays from 2024 to 2026; further slip to 2027 possible.

WHAT THE AGENT FOUND

Three space economy leaders disclosed major growth catalysts: Viasat's constellation now fully operational, Spire awarded multi-year government contract, Rocket Lab secured $397M Space Force program.

3 sources · 0 filings →

% = share price change, close 27 Aug → 25 Sep 2026

VSAT +0.40% month

Constellation operational then SPIR · RKLB

ViaSat-3 F2 entered service Sept 17, completing constellation with 1+ Tbps capacity.

Add to my account Full analysis →

3 sources · 0 filings →

Agent-generated research. May contain errors or omissions. Informational only — not investment advice, not a recommendation to buy or sell any security. Quotes via Yahoo Finance (unaffiliated).

US EXTREME WEATHER LIVE ALERTS

Extreme Weather Today

COASTAL FLOOD

North Carolina to Massachusetts1-3 ft

Moderate to major flooding likely with waves reaching 12-22 feet.

COASTAL FLOOD

Maryland and Virginia2-3 ft

Water 2-3 feet above ground will close roads and threaten homes and businesses.

HIGH WIND

New Jersey and Delaware60 mph gust

Damaging winds will blow down trees and power lines with widespread power outages expected.

WHAT THE AGENT FOUND

A rare September nor'easter is bringing severe coastal flooding and damaging winds to the Northeast through Sunday. Millions face inundation, power outages, and road closures.

3 sources · 0 filings →

COASTAL FLOOD 1-3 ft

North Carolina to Massachusetts · Maryland and Virginia · New Jersey and Delaware

Moderate to major flooding likely with waves reaching 12-22 feet.

Add to my account Full analysis →

3 sources · 0 filings →

Agent-generated summary. May contain errors or omissions. Always follow official National Weather Service guidance for safety decisions.

Agent Research - Sat, Sep 26, 2026

Semiconductor Research

Hyperscaler Research

Energy Research

Biotech Research

Defense Research

Space Research

Extreme Weather Today